Among the predicted mRNA targets of miR-22 are known cancer-related genes such as phosphatase and tensin homolog (PTEN), metadherin (MTDH), cyclin-dependent kinase 6 (CDK6), and laminin γ1 (LAMC1). This evidence concerns the gene LAMC1 and cancer.